OUT OF MIND
Would you like to react to this message? Create an account in a few clicks or log in to continue.
Latest topics
» Is it possible to apply positive + in favor Newton III Motion Law as a dynamic system in a motor engine
Informed consent disclosure to vaccine trial subjects EmptySat Mar 23, 2024 11:33 pm by globalturbo

» Meta 1 Coin Scam Update - Robert Dunlop Arrested
Informed consent disclosure to vaccine trial subjects EmptySat Mar 23, 2024 12:14 am by RamblerNash

» As We Navigate Debs Passing
Informed consent disclosure to vaccine trial subjects EmptyMon Jan 08, 2024 6:18 pm by Ponee

» 10/7 — Much More Dangerous & Diabolical Than Anyone Knows
Informed consent disclosure to vaccine trial subjects EmptyThu Nov 02, 2023 8:30 pm by KennyL

» Sundays and Deb.....
Informed consent disclosure to vaccine trial subjects EmptySun Oct 01, 2023 9:11 pm by NanneeRose

» African Official Exposes Bill Gates’ Depopulation Agenda: ‘My Country Is Not Your Laboratory’
Informed consent disclosure to vaccine trial subjects EmptyThu Sep 21, 2023 4:39 am by NanneeRose

» DEBS HEALTH
Informed consent disclosure to vaccine trial subjects EmptySun Sep 03, 2023 10:23 am by ANENRO

» Attorney Reveals the “Exculpatory” Evidence Jack Smith Possesses that Exonerates President Trump
Informed consent disclosure to vaccine trial subjects EmptyTue Aug 29, 2023 10:48 am by ANENRO

» Update From Site Owner to Members & Guests
Informed consent disclosure to vaccine trial subjects EmptyTue Aug 29, 2023 10:47 am by ANENRO

» New global internet censorship began today
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 21, 2023 9:25 am by NanneeRose

» Alienated from reality
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 4:29 pm by PurpleSkyz

» Why does Russia now believe that Covid-19 was a US-created bioweapon?
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 4:27 pm by PurpleSkyz

»  Man reports history of interaction with seemingly intelligent orbs
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:34 pm by PurpleSkyz

» Western reactions to the controversial Benin Bronzes
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:29 pm by PurpleSkyz

» India unveils first images from Moon mission
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:27 pm by PurpleSkyz

» Scientists achieve nuclear fusion net energy gain for second time
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:25 pm by PurpleSkyz

» Putin Signals 5G Ban
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:07 pm by PurpleSkyz

» “Texas Student Dies in Car Accident — Discovers Life after Death”
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:05 pm by PurpleSkyz

» The hidden history taught by secret societies
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:03 pm by PurpleSkyz

» Vaccines and SIDS (Crib Death)
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 3:00 pm by PurpleSkyz

» Sun blasts out highest-energy radiation ever recorded, raising questions for solar physics
Informed consent disclosure to vaccine trial subjects EmptyMon Aug 07, 2023 2:29 pm by PurpleSkyz

» Why you should be eating more porcini mushrooms
Informed consent disclosure to vaccine trial subjects EmptySun Aug 06, 2023 10:38 am by PurpleSkyz


You are not connected. Please login or register

Informed consent disclosure to vaccine trial subjects

Go down  Message [Page 1 of 1]

PurpleSkyz

PurpleSkyz
Admin

Informed consent disclosure to vaccine trial subjects
Published on August 14, 2021
Written by nih.gov

Informed consent disclosure to vaccine trial subjects Vaccine-image-4

Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs.

The aim of the study was to determine if sufficient literature exists to require clinicians to disclose the specific risk that COVID-19 vaccines could worsen disease upon exposure to challenge or circulating virus.

Methods used to conduct the study:

Published literature was reviewed to identify preclinical and clinical evidence that COVID-19 vaccines could worsen disease upon exposure to challenge or circulating virus. Clinical trial protocols for COVID-19 vaccines were reviewed to determine if risks were properly disclosed.

Results of the study:

COVID-19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated.
Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE).
This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Conclusions drawn from the study and clinical implications:

The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.

References


  1. [list=references-and-notes-list]
  2. Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD. Vaccine‐induced enhancement of viral infections. Vaccine. 2009;27:505‐512. – PMC – PubMed
  3. Boyoglu‐Barnum S, Chirkova T, Anderson LJ. Biology of infection and disease pathogenesis to guide RSV vaccine development. Front Immunol. 2019;10:1675. – PMC – PubMed
  4. Chen WH, Hotez PJ, Bottazzi ME. Potential for developing a SARS‐CoV receptor‐binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)‐19. Human Vacc Immunother. 2020;16:1239‐1242. – PMC – PubMed
  5. Jiang S, He Y, Liu S. SARS vaccine development. Emerg Infect Dis. 2005;11:1016‐1020. – PMC – PubMed
  6. Tseng CT, Sbrana E, Iwata‐Yoshikawa N, et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One. 2012;7:e35421. – PMC – PubMed


[/list]
See more here: pubmed.ncbi.nlm.nih.gov

https://principia-scientific.com/informed-consent-disclosure-to-vaccine-trial-subjects/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+psintl+%28Principia+Scientific+Intl+-+Latest+News%29

Thanks to: https://principia-scientific.com

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum